Cartesian Therapeutics
RNAC
#6732
Rank
NZ$0.78 B
Marketcap
$32.97
Share price
3.61%
Change (1 day)
-40.08%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.53

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.53. In 2021 the company made an earnings per share (EPS) of -$0.40 an increase over its 2020 EPS that were of -$1.15.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.53
2021-$0.40-65.22%
2020-$1.15-43.44%
2019-$2.03-58.08%
2018-$4.85-9.35%
2017-$5.35-29.16%
2016-$7.55